Recent major advances in cardiovascular pharmacotherapy James MilnerAndreia CunhaNatália António Review 27 March 2018 Pages: 853 - 862
Active pharmacovigilance in China: recent development and future perspectives Xinling LiHaona LiJielai Xia Review 10 April 2018 Pages: 863 - 871
Pharmacokinetics and -dynamics of intramuscular and intranasal naloxone: an explorative study in healthy volunteers Arne Kristian SkulbergIda TylleskarOla Dale Clinical Trial 22 March 2018 Pages: 873 - 883
Effects of vitamin K epoxide reductase complex 1 gene polymorphisms on warfarin control in Japanese patients with left ventricular assist devices (LVAD) Kazuki NakagitaKyoichi WadaMitsutaka Takada Pharmacodynamics 21 May 2018 Pages: 885 - 894
Policies and availability of orphan medicines in outpatient care in 24 European countries Kati SarnolaRiitta AhonenJohanna Timonen Pharmacoeconomics 09 April 2018 Pages: 895 - 902
N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians Eleni AklilluJuan Antonio CarrilloNatasa Djordjevic Pharmacogenetics Open access 27 March 2018 Pages: 903 - 911
Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries Madelé van DykJean-Claude MarshallAndrew Rowland Pharmacokinetics and Disposition 23 March 2018 Pages: 913 - 920
Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants Yewei ChenDan WuZhiping Li Pharmacokinetics and Disposition 30 March 2018 Pages: 921 - 930
Drug-drug interaction of cefiderocol, a siderophore cephalosporin, via human drug transporters Takayuki KatsubeShiro MiyazakiToshihiro Wajima Pharmacokinetics and Disposition 07 April 2018 Pages: 931 - 938
Safety of brotizolam in hospitalized patients Ophir LavonShmuel Bejel Pharmacoepidemiology and Prescription 22 March 2018 Pages: 939 - 943
Patterns of direct oral anticoagulant drug prescription in France in 2010–2013: a study in the Midi-Pyrénées area Hugo DiazHaleh BagheriJordan Birebent Pharmacoepidemiology and Prescription 27 March 2018 Pages: 945 - 951
Trends and variations in the prescribing of secondary preventative cardiovascular therapies for non-ST elevation myocardial infarction (NSTEMI) in Malaysia Padmaa VenkatasonNur Lisa ZaharanAhmad Syadi Mahmood Zuhdi Pharmacoepidemiology and Prescription Open access 26 March 2018 Pages: 953 - 960
Relationship between frailty, polypharmacy, and underprescription in older adults living in nursing homes Marta Gutiérrez-ValenciaMikel IzquierdoNicolás Martínez-Velilla Pharmacoepidemiology and Prescription 27 March 2018 Pages: 961 - 970
Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden P. FriskK. AggeforsO. Weiland Pharmacoepidemiology and Prescription Open access 09 April 2018 Pages: 971 - 978
Paroxetine ameliorates whole-body allodynia Hiroki ShiwakuToru Nishikawa Letter to the Editor 11 April 2018 Pages: 979 - 980
Updated analysis on polypharmacy and mortality from the ESTHER study Ben SchöttkerDana Clarissa MuhlackHermann Brenner Letter to the Editor 06 April 2018 Pages: 981 - 982
Serious adverse drug reactions with sacubitril/valsartan Entresto®: a French pharmacovigilance survey Florence MoulisVanessa RousseauJean-Louis Montastruc Letter to the Editor 14 April 2018 Pages: 983 - 984